Evercore ISI raised the firm’s price target on Mettler-Toledo to $1,450 from $1,375 and keeps an In Line rating on the shares. In MedTech, utilization remains positive into Q3 and the capex outlook into the next year remains “healthy,” says Evercore. In life science tools, bioprocess trends for are on track for improvement in the second half, but the debate is around the instrument outlook and China stimulus given the recent run in stocks in the space, the analyst tells investors in MedTech and Tools Q3 preview.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MTD:
- Wells Fargo initiates Mettler-Toledo with an Equal Weight, $1,400 price target
- Mettler-Toledo initiated with an Equal Weight at Wells Fargo
- Mettler-Toledo price target raised to $1,550 from $1,510 at Stifel
- Mettler-Toledo price target raised to $1,375 from $1,260 at Baird
- SPY ETF Update, 8/2/2024